{"nct_id":"NCT04576156","title":"A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2021-04-12","start_date_type":"ACTUAL","primary_completion_date":"2028-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2028-06-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GERN"]}